These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9286371)
1. B7-2+ low density APCS are as effective as B7-2- small resting B cells in inducing specific unresponsiveness to minor histocompatibility (miH) antigen(s) in vivo. Niimi M; Rawsthorne MA; Morris PJ; Wood KJ Adv Exp Med Biol; 1997; 417():265-8. PubMed ID: 9286371 [No Abstract] [Full Text] [Related]
2. Resting B cells as tolerogens in vivo but only for minor histocompatibility antigens: evidence for activation of resting B cells in vivo. Niimi M; Roelen DL; Wong W; Hara M; Morris PJ; Wood KJ Transplantation; 1997 Nov; 64(9):1330-5. PubMed ID: 9371676 [TBL] [Abstract][Full Text] [Related]
3. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506 [TBL] [Abstract][Full Text] [Related]
4. Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. Niimi M; Hara M; Witzke O; Morris PJ; Wood KJ Transplantation; 1998 Dec; 66(12):1786-92. PubMed ID: 9884277 [TBL] [Abstract][Full Text] [Related]
5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
6. Small, resting B cells induce prolonged survival of cardiac allografts mismatched for single minor, but not multiple minor, single major, or multiple major and minor histocompatibility antigens. Niimi M; Morris PJ; Wood KJ Transplant Proc; 1997; 29(1-2):1171. PubMed ID: 9123259 [No Abstract] [Full Text] [Related]
7. Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Liang X; Lu L; Zhang H; Vickers T; Fung JJ; Qian S Transplant Proc; 2001; 33(1-2):235. PubMed ID: 11266796 [No Abstract] [Full Text] [Related]
8. Role of CTLA 4-Ig on induction of unresponsiveness to multiple minor alloantigens. Gorczynski RM; Kiziroglu F Transpl Int; 1994; 7 Suppl 1():S599-601. PubMed ID: 11271318 [TBL] [Abstract][Full Text] [Related]
9. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time. Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773 [TBL] [Abstract][Full Text] [Related]
10. Rejection of mouse cardiac allografts by costimulation in trans. Mandelbrot DA; Kishimoto K; Auchincloss H; Sharpe AH; Sayegh MH J Immunol; 2001 Aug; 167(3):1174-8. PubMed ID: 11466331 [TBL] [Abstract][Full Text] [Related]
11. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells. Morokata T; Kato T; Igarashi O; Nariuchi H Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells can be used as physiological adjuvant in vivo. Moser M; Sornasse T; De Smedt T; Van Mechelen M; Heynderickx M; Flamand V; De Becker G; Thielemans K; Urbain J; Leo O Adv Exp Med Biol; 1995; 378():501-5. PubMed ID: 8526128 [No Abstract] [Full Text] [Related]
14. Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells. Gorczynski RM; Kiziroglu F Transplantation; 1994 Jul; 58(1):51-8. PubMed ID: 8036708 [TBL] [Abstract][Full Text] [Related]
15. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220 [No Abstract] [Full Text] [Related]
17. Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules. Kosco-Vilbois MH; Gray D; Scheidegger D; Julius M J Exp Med; 1993 Dec; 178(6):2055-66. PubMed ID: 7504055 [TBL] [Abstract][Full Text] [Related]
18. Differential immunogenic expression of an H-2-linked histocompatibility antigen on different tissues. Differences in survival between heart, thyroid, and skin allografts. Isakov N; Yankelevich B; Segal S; Feldman M Transplantation; 1979 Jul; 28(1):31-5. PubMed ID: 377590 [No Abstract] [Full Text] [Related]
19. Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival. Chen J; He Q; Zhang R; Chu Y; Wang Y; Liu Q; Xiong S Clin Exp Immunol; 2004 Nov; 138(2):245-50. PubMed ID: 15498033 [TBL] [Abstract][Full Text] [Related]
20. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation. Bhattacharyya S; Cowan MJ Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]